Reduction in Recruitment Time: By automating the identification of suitable candidates, the company reduced its recruitment time by 50%, allowing clinical trials to commence more quickly and efficiently.

Decrease in Screening Failures: The AI-driven platform accurately matched patient data to trial requirements, resulting in a 30% reduction in the number of ineligible participants who failed the screening process.

Increase in Enrollment Efficiency: The streamlined recruitment process and automated candidate identification improved the efficiency of enrolling participants, reducing the workload on trial coordinators by 20%

Business Challenge:
A large pharmaceutical company conducting multiple clinical trials faced challenges in identifying suitable candidates from a vast pool of patients. Traditional methods of recruiting participants relied on manual screening, which was time-consuming, inefficient, and often led to delays in trial commencement. Furthermore, many patients who joined trials were later found to be ineligible, leading to costly setbacks. The company needed a more efficient, data-driven approach to streamline the recruitment process, improve accuracy, and ensure that only eligible candidates were selected for the trials.

Solution:
Syntes AI implemented an AI-driven candidate identification platform designed to streamline the selection of suitable participants for clinical trials. The platform analyzed vast amounts of patient data, including medical history, demographics, treatment records, and genetic information, to match patients with the eligibility criteria of specific clinical trials. By using advanced machine learning algorithms, the system quickly identified candidates who were most likely to meet the trial requirements, reducing the burden on trial recruiters and minimizing the risk of ineligible candidates entering the trials.

Key Features for Clinical Trial and Research Teams:

  • AI-Powered Patient Matching: Syntes AI analyzes large datasets of patient records and medical information to identify individuals who meet the specific eligibility criteria for each clinical trial.
  • Faster Candidate Identification: The platform rapidly scans patient data, reducing the time it takes to identify eligible candidates and speeding up the recruitment process for clinical trials.
  • Reduction in Screening Failures: By accurately matching patient profiles to trial criteria, the platform minimizes the risk of ineligible participants being selected, thereby reducing costly screening failures.
  • Integration with Healthcare Data Sources: Syntes AI integrates with electronic health records (EHR), patient databases, and genetic information sources to provide a comprehensive view of potential candidates.

Steps to Implement:

  1. Data Integration and Setup: Use Syntes AI to integrate patient data from various sources, including EHR systems, genetic databases, and healthcare providers, creating a unified platform for candidate analysis.
  2. AI-Driven Eligibility Matching: Apply AI algorithms to analyze patient data and match potential participants with the eligibility criteria for specific clinical trials, ensuring that only qualified candidates are identified.
  3. Automated Candidate Shortlisting: Use the platform to generate a shortlist of the most suitable candidates for each trial, based on patient profiles and trial requirements, significantly reducing manual recruitment efforts.
  4. Continuous Monitoring and Updates: Continuously monitor the platform for real-time updates on patient data and trial criteria, ensuring that new eligible candidates are identified as soon as they become available.

Summary: 
Syntes AI’s AI-driven clinical trial candidate identification platform helps pharmaceutical companies and research institutions efficiently and accurately identify suitable participants for clinical trials. By leveraging machine learning to analyze patient data and match individuals to trial eligibility criteria, the platform reduces recruitment time, minimizes screening failures, and improves the overall quality of clinical trial participants. This solution is essential for organizations looking to accelerate their clinical trials, enhance participant selection, and achieve more reliable trial results.